Co-morbidities: The heart of the matter
26 July 2024
View abstract
Speakers
Olof Elvstam
Lund University
Detailed modelling of viremia exposure does not independently predict cardiovascular disease in people with HIV
- presentation-slides.pptx (993.4 KB)
Matthew Romo
U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research
Dolutegravir-containing antiretroviral therapy and incident hypertension: findings from a prospective cohort in Kenya, Nigeria, Tanzania, and Uganda
- presentation-slides.pptx (1.23 MB)
Shalom Kawonga Dunga
Elizabeth Glaser Pediatric Aids Foundation
Integrating non-communicable disease screening and treatment in antiretroviral clinics: insights from Malawi
- presentation-slides.pptx (2.9 MB)
Carl J. Fichtenbaum
University of Cincinnati
Abacavir is associated with elevated risk for cardiovascular events in the REPRIEVE trial
- presentation-slides.pptx (2.83 MB)
Stefan Esser
Clinic of Dermatology, Department of Venereology, University Hospital Essen
Olof Elvstam
Lund University
Jienchi Dorward
University of Oxford
Matthew Romo
U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research
Shalom Kawonga Dunga
Elizabeth Glaser Pediatric Aids Foundation
Carl J. Fichtenbaum
University of Cincinnati
Q&A and conclusion